Stocks and securities in focus
Security ▼ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Viking Therapeutics Inc | -1.900% | -7.424% | 4.335% | 191.961% | 255.162% | 1177.778% | - |
Vertex Pharmaceuticals Inc. | -1.460% | 3.337% | 11.264% | 30.245% | 10.830% | 132.580% | 176.591% |
Utah Medical Products Inc | -0.780% | - | - | - | - | - | - |
Revance Therapeutics Inc. | 2.880% | - | - | - | - | - | - |
Ocular Therapeutix Inc. | 0.760% | 9.091% | 16.200% | -4.803% | 35.558% | -50.966% | 87.661% |
Intra-Cellular Therapies Inc. | -0.830% | -1.626% | -11.029% | 4.131% | -7.209% | 97.712% | 431.168% |
Healthequity Inc. | - | 1.399% | -3.974% | 38.095% | 21.849% | 13.815% | - |
Evotec SE | -1.140% | -3.440% | -26.629% | -50.962% | -54.658% | -72.257% | -57.891% |
Eli Lilly Corp. | 3.010% | 2.491% | 5.649% | 75.867% | 36.364% | 341.176% | 594.712% |
Cardiff Oncology Inc. | -6.570% | 3.715% | -17.791% | 114.469% | 154.559% | -50.370% | -4.286% |
AstraZeneca plc | 2.830% | -1.118% | 10.202% | 1.762% | 15.794% | 50.869% | 111.668% |
Agenus Inc. | -1.970% | - | - | - | - | - | - |
AC Immune Ltd | 1.380% | -5.375% | 30.562% | 55.681% | -33.676% | -44.135% | - |